Single institution early clinical experience with the Scepter Mini balloon catheter

Neuroradiol J. 2021 Dec;34(6):562-567. doi: 10.1177/19714009211013495. Epub 2021 May 20.

Abstract

Background: The use of liquid embolic agents in the endovascular treatment of dural arteriovenous (dAVFs) fistulas and brain arteriovenous malformations (AVMs) has become common practice. The use of dual lumen balloon microcatheters has greatly improved the efficacy of liquid embolization. The purpose of this series is to discuss our early experience with the Scepter Mini dual lumen balloon microcatheter.

Methods: A retrospective chart review was performed of all patients who underwent embolization with the Scepter Mini dual lumen balloon at a single institution. Technical details and procedural complications were recorded for each case.

Results: In total, 10 Scepter Mini dual lumen balloon microcatheters were used in nine patients. All patients except two were treated for AVMs. Technical success was achieved in all but one case where one balloon had to be discarded due to precipitation of the tantalum powder. Average vessel diameter where the balloon was inflated was 1.1 mm (0.8-2.4 mm). It provided flow arrest in 100% of cases with no cases of reflux of embolic material. Balloon "jump back" was found to occur in 44.4% (4/9) of cases. Seven out of nine cases used Onyx, and two cases used n-butyl cyanoacrylate.

Conclusions: The Scepter Mini is a new dual lumen balloon ideal for distal access and can be used for embolization with liquid embolic agents with a high degree of technical success. Its great benefit is the immediate and safe flow arrest of distal vasculature upon balloon inflation. One important consideration for effective embolization is early identification of balloon jump back.

Keywords: Arteriovenous fistulas; arteriovenous malformations; dual lumen balloon; liquid embolic.

MeSH terms

  • Balloon Occlusion*
  • Catheters
  • Central Nervous System Vascular Malformations*
  • Embolization, Therapeutic* / adverse effects
  • Humans
  • Polyvinyls
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Polyvinyls